ASIT-biotech Information

ASIT biotech is a Belgian clinical stage biopharmaceutical company focused on the development and future commercialisation of a range of breakthrough immunotherapy products for the treatment of allergies. Thanks to its innovative ASIT+TM technology platform, ASIT biotech is currently the only developer of AIT product candidates consisting of a unique mixture of highly purified natural allergen fragments in an optimal size selection. This innovation results in a short treatment, expected to improve patient compliance and real-life effectiveness.

Website	https://www.asitbiotech.com/
Ticker	ASIT
Revenue	$637000
Employees	10 (0 on RocketReach)
Founded	1997
Address	5 Ave Ariane, Bruxelles Woluwé-Saint-Lambert, Brussels Capital 1200, BE
Phone	+32 2 264 03 90
Fax	(322) 264-0399
Technologies	JavaScript , HTML , Google Analytics +9 more (view full list)
Industry	Biotechnology, Business Services General, Research & Development, Business Services, Science and Engineering, Health Care, Pharmaceutical
Keywords	Allergy Immunotherapy, Allergy Treatment, Immunotherapy, Biopharmaceutical, Biotechnology, Immunotherapeutic Agents, Clinical Stage, Breakthrough Therapies, Clinical Trials, Drug Development, Pharmaceutical Research, Immunological Research, Innovative Treatments, Therapeutic Development, Novel Therapies, New Treatments, Healthcare
Competitors	Novartis, Pfizer, AstraZeneca, Boehringer Ingelheim, Merck Group, Stallergenes Greer, Circassia DE, Lycera, Allergenis, TheraBiologics, Inc +40 more (view full list)
SIC	SIC Code 28 Companies, SIC Code 283 Companies
NAICS	NAICS Code 32541 Companies, NAICS Code 325 Companies, NAICS Code 32 Companies, NAICS Code 3254 Companies